Erratum to: KPT-330, a potent and selective exportin-1 (XPO-1) inhibitor, shows antitumor effects modulating the expression of cyclin D1 and survivin in prostate cancer models.

Subjects

Subjects :

PUBLISHED errata
CANCER periodicals
ANTINEOPLASTIC agents
CYCLINS
PROSTATE cancer

Details

Language :

English

ISSN :

14712407

Volume :

16

Database :

Complementary Index

Journal :

BMC Cancer

Publication Type :

Academic Journal

Accession number :

112255496

Full Text :

https://doi.org/10.1186/s12885-015-2046-7